There was no significant difference in serum TFF1, TFF2, and TFF3 levels in any other clinicopathological status of breast cancer including histological types, tumor size, nodal status, nuclear grade, lymphatic invasion, venous invasion, status of ER, status of PR, HER2, Ki67 and molecular subtypes. The gene discussed is TFF3; the disease is breast cancer.